Penicillamine

FDA Approved: * May 7, 2019
Pharm Company: * AMERIGEN PHARMS LTD
Category: Arthritis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Penicillamine Overview

Penicillamine, sold under the trade names of Cuprimine among others, is a medication primarily used for the treatment of Wilson's disease.[1] It is also used for people with kidney stones who have high urine cystine levels, rheumatoid arthritis, and various heavy metal poisonings.[1][2] It is taken by mouth.[2] Common side effects include rash, loss of appetite, nausea, diarrhea, and low blood white blood cell levels.[1&a...

Read more Penicillamine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Penicillamine

Recent Penicillamine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Penicillamine
  • Capsule: 125mg, 250mg
  • Tablet: 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Penicillamine: (4 results)

Sorted by National Drug Code
  • 0378-0709 D-penamine 125 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0591-4171 Penicillamine 250 mg Oral Capsule by Actavis Pharma, Inc.
  • 43975-309 Penicillamine 250 mg Oral Capsule by Amerigen Pharmaceuticals, Inc.
  • 68682-020 Penicillamine 250 mg Oral Capsule by Oceanside Pharmaceuticals

Other drugs which contain Penicillamine or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA